Subgroup analyses in randomized clinical trials: Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy.

Heinz DrexelStuart J PocockBasil S LewisChristoph H SaelyJuan Carlos KaskiGiuseppe M C RosanoGerda TautermannKurt HuberJoern F DopheideArthur MaderAlexander NiessnerGianluigi SavareseThomas A SchmidtAnne Grete SembJuan TamargoSven WassmannMartin ClodiKeld Per KjeldsenStefan Agewall

Published in: European heart journal. Cardiovascular pharmacotherapy (2021)

Keyphrases

smoking cessation
phase iii
double blind
open label
study protocol